Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Residex is a Japanese venture capital firm exclusively focused on the life sciences and healthcare sectors. Based in Tokyo, the firm invests in early-stage biotechnology, medical device, and digital health companies, primarily within Japan but also internationally. Residex aims to bridge the gap between academic research and commercial success by providing both capital and strategic management support to its portfolio companies. Their investment strategy emphasizes innovative therapeutic modalities and medical technologies with the potential to address significant unmet medical needs. The firm is known for its hands-on approach, often assisting university spin-offs in their transition to clinical-stage companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Residex Ventures.